One-month Outcome of Acute Coronary Syndrome Patients with Positive Creatine Kinase-MB and Negative Troponin; a Brief Report
Iranian Journal of Emergency Medicine,
Vol. 3 No. 4 (2016),
29 October 2016
,
Page 153-149
https://doi.org/10.22037/ijem.v3i4.13934
Abstract
Introduction: Biochemical markers of myocardial injuries have radical importance in diagnosis or dismissing cardiac events, especially in cases that electrocardiographic findings are not present. Therefore, this study was designed aiming to appraise 1-month outcome of patients presenting to emergency department (ED) following acute coronary syndrome (ACS) with positive creatine kinase-MB (CK-MB) and negative troponin. Methods:This prospective cross-sectional study was done on patients presenting to ED with complaint of acute chest pain and diagnosis of ACS. Patients who did not have a clear electrocardiographic finding indicating acute myocardial infarction (MI) (ST segment elevation) and had positive CK-MB and negative troponin in laboratory tests of serum were included. Demographic data and baseline characteristics, CK serum level, CK-MB, troponin, and 30-day outcome of the patients were analyzed using SPSS version 19. Results: 13759 patients had visited the ED with complaint of chest pain during the study period (57% female). 1003 (7.3%) patients had positive troponin test and 12704 (92.3%) had negative CK-MB index and were therefore eliminated from the study. Finally, 52 (0.4%) had both positive CK-MB and negative troponin indices. 35 (67.3%) of them were discharged from ED after serial electrocardiography and negative troponin test. 11 (21.2%) were admitted to critical care unit but were discharged due to having 2 negative troponin tests in 12 hours and normal serial electrocardiogram. 6 (11.5%) were referred for surgical interventions. No mortality was seen in 1-month follow-up. Conclusion: Based on the results of the present study, only 0.4% of ACS patients presenting to the studied ED had positive CK-MB and negative troponin indices. During 1-month follow-up, no case of mortality or MI was observed among them. Only 2 (3.8%) cases needed surgical intervention.
- درد قفسه سینه؛ تروپونین؛ سندرم کرونری حاد؛ بیومارکرها
How to Cite
References
Dolatabadi AA, Kashani P, Hatamabadi H, Kariman H, Baratloo A. Using risk factors to help in the diagnosis of acute myocardial infarction in patients with non-diagnostic electrocardiogram changes in emergency department. Journal of Emergency Practice and Trauma. 2015;1(1):3-6.
Valadkhani S, Jalili M, Hesari E, Mirfazaelian H. Validation of the North American Chest Pain Rule in Prediction of Very Low-Risk Chest Pain; a Diagnostic Accuracy Study. EMERGENCY-An Academic Emergency Medicine Journal. 2016;4.
Kariman H, Harati S, Safari S, Baratloo A, Pishgahi M. Validation of EGSYS Score in Prediction of Cardiogenic Syncope. Emergency medicine international. 2015;2015.
Keller T, Zeller T, Peetz D, Tzikas S, Roth A, Czyz E, et al. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. New England Journal of Medicine. 2009;361(9):868-77.
Gibler WB, Young GP, Hedges JR, Lewis LM, Smith MS, Carleton SC, et al. Acute myocardial infarction in chest pain patients with nondiagnostic ECGs: serial CK-MB sampling in the emergency department. Annals of emergency medicine. 1992;21(5):504-12.
Mair J, Artner-Dworzak E, Dienstl A, Lechleitner P, Morass B, Smidt J, et al. Early detection of acute myocardial infarction by measurement of mass concentration of creatine kinase-MB. The American journal of cardiology. 1991;68(17):1545-50.
Volz KA, McGillicuddy DC, Horowitz GL, Sanchez LD. Creatine kinase-MB does not add additional benefit to a negative troponin in the evaluation of chest pain. The American journal of emergency medicine. 2012;30(1):188-90.
Galla JM, Mahaffey KW, Sapp SK, Alexander JH, Roe MT, Ohman EM, et al. Elevated creatine kinase-MB with normal creatine kinase predicts worse outcomes in patients with acute coronary syndromes: results from 4 large clinical trials. American heart journal. 2006;151(1):16-24.
Lin JC, Apple FS, Murakami MM, Luepker RV. Rates of positive cardiac troponin I and creatine kinase MB mass among patients hospitalized for suspected acute coronary syndromes. Clinical chemistry. 2004;50(2):333-8.
Ross G, Bever FN, Uddin Z, Hockman EM. Troponin I sensitivity and specificity for the diagnosis of acute myocardial infarction. JOURNAL-AMERICAN OSTEOPATHIC ASSOCIATION. 2000;100(1):29-31.
Kim J, Hashim IA. The clinical utility of CK-MB measurement in patients suspected of acute coronary syndrome. Clinica Chimica Acta. 2016;456:89-92.
Puleo PR, Guadagno PA, Roberts R, Scheel MV, Marian AJ, Churchill D, et al. Early diagnosis of acute myocardial infarction based on assay for subforms of creatine kinase-MB. Circulation. 1990;82(3):759-64.
Kitawaki T, Oka H, Usui S, Hirohata S, Kusachi S. New Estimation Method of Total Creatine Phosphokinase Release in Early Stage in Acute Myocardial Infarction. International Journal of Cardiovascular and Cerebrovascular Disease. 2014;2(2):18-27.
Rao SV, Ohman EM, Granger CB, Armstrong PW, Gibler WB, Christenson RH, et al. Prognostic value of isolated troponin elevation across the spectrum of chest pain syndromes. The American journal of cardiology. 2003;91(8):936-40.
Newby LK, Roe MT, Chen AY, Ohman EM, Christenson RH, Pollack CV, et al. Frequency and clinical implications of discordant creatine kinase-MB and troponin measurements in acute coronary syndromes. Journal of the American College of Cardiology. 2006;47(2):312-8.
- Abstract Viewed: 860 times
- PDF (فارسی) Downloaded: 1012 times
- HTML (فارسی) Downloaded: 84 times